News briefing: Amarin's panel could put Vascepa patents in jeopardy; Santhera nabs a Duchenne drug
Amarin’s fish oil empire may be slipping out of its grasp.
On Wednesday, in the latest twist in a long legal battle, the appeal panel …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
